FDA is­sues draft guid­ance for clin­i­cal re­search in­to psy­che­delics

Sev­er­al star­tups study­ing psy­che­delics have re­ceived de­cent cap­i­tal in­vest­ments and start­ed test­ing the ef­fi­ca­cy of their treat­ments, and now the FDA has re­leased a draft …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.